XXII

22nd Century Group
XXII

$0.2657
6.22%

Market Cap: $2.46M

 

About: 22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Employees: 64

0
Funds holding %
of 6,686 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

8.71% less ownership

Funds ownership: 10.95% [Q1] → 2.24% (-8.71%) [Q2]

35% less funds holding

Funds holding: 49 [Q1] → 32 (-17) [Q2]

65% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 26

86% less capital invested

Capital invested by funds: $1M [Q1] → $138K (-$863K) [Q2]

95% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 21

Research analyst outlook

We haven’t received any recent analyst ratings for XXII.

Financial journalist opinion

Based on 6 articles about XXII published over the past 30 days